17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
In the near and mid-term, companies must take decisive steps in order to ensure the financial health...
Read More >
New York State’s deadline for training employees on preventing sexual harassment and discrimination...
Read More >
Key Takeaways - On July 28, 2020, the U.S. Treasury Department, as chair of the Committee on Foreig...
Read More >
Northrop Grumman has agreed to pay $12,375,000 to settle a class action brought under the Employee R...
Read More >
Our previous Wage and Hour Watch post summarized DOL’s recent Notice of Proposed Rulemaking on the ...
Read More >
So about those May jobs numbers . . . . The return of 2.5 million jobs in May was a welcome and larg...
Read More >